54 related articles for article (PubMed ID: 7842490)
1. Target-induced anergy of natural killer cytotoxic function is restricted to the NK-target conjugate subset.
Jewett A; Bonavida B
Cell Immunol; 1995 Jan; 160(1):91-7. PubMed ID: 7842490
[TBL] [Abstract][Full Text] [Related]
2. Anergic natural killer cells educated by tumor cells are associated with a poor prognosis in patients with advanced pancreatic ductal adenocarcinoma.
Yang C; Cheng H; Zhang Y; Fan K; Luo G; Fan Z; Huang Q; Lu Y; Jin K; Wang Z; Yu X; Liu C
Cancer Immunol Immunother; 2018 Dec; 67(12):1815-1823. PubMed ID: 30167864
[TBL] [Abstract][Full Text] [Related]
3. Target-cell-induced anergy in natural killer cells: suppression of cytotoxic function.
Das S; Varalakshmi C; Khar A
Cancer Immunol Immunother; 2000 May; 49(2):109-15. PubMed ID: 10823421
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneity of murine adherent interleukin-2-activated killer cells. Differential effect of prostaglandin E2 and forskolin.
Vaillier D; Daculsi R; Gualde N
Cancer Immunol Immunother; 1995 Jan; 40(1):65-71. PubMed ID: 7828169
[TBL] [Abstract][Full Text] [Related]
5. Potential rescue, survival and differentiation of cancer stem cells and primary non-transformed stem cells by monocyte-induced split anergy in natural killer cells.
Jewett A; Tseng HC
Cancer Immunol Immunother; 2012 Feb; 61(2):265-274. PubMed ID: 22116348
[TBL] [Abstract][Full Text] [Related]
6. Bi-Specific Killer Cell Engager Enhances NK Cell Activity against Interleukin-13 Receptor Alpha-2 Positive Gliomas.
Pawlowski KD; Duffy JT; Tiwari A; Zannikou M; Balyasnikova IV
Cells; 2023 Jun; 12(13):. PubMed ID: 37443750
[TBL] [Abstract][Full Text] [Related]
7. Locked and Loaded: Mechanisms Regulating Natural Killer Cell Lytic Granule Biogenesis and Release.
Ham H; Medlyn M; Billadeau DD
Front Immunol; 2022; 13():871106. PubMed ID: 35558071
[TBL] [Abstract][Full Text] [Related]
8. Proliferation of Highly Cytotoxic Human Natural Killer Cells by OX40L Armed NK-92 With Secretory Neoleukin-2/15 for Cancer Immunotherapy.
Guo M; Sun C; Qian Y; Zhu L; Ta N; Wang G; Zheng J; Guo F; Liu Y
Front Oncol; 2021; 11():632540. PubMed ID: 33937033
[TBL] [Abstract][Full Text] [Related]
9. Cbl-b Is Upregulated and Plays a Negative Role in Activated Human NK Cells.
Lu T; Chen L; Mansour AG; Yu MJ; Brooks N; Teng KY; Li Z; Zhang J; Barr T; Yu J; Caligiuri MA
J Immunol; 2021 Feb; 206(4):677-685. PubMed ID: 33419766
[TBL] [Abstract][Full Text] [Related]
10. Natural Killer Cells: Diverse Functions in Tumor Immunity and Defects in Pre-neoplastic and Neoplastic Stages of Tumorigenesis.
Jewett A; Kos J; Kaur K; Safaei T; Sutanto C; Chen W; Wong P; Namagerdi AK; Fang C; Fong Y; Ko MW
Mol Ther Oncolytics; 2020 Mar; 16():41-52. PubMed ID: 31930165
[TBL] [Abstract][Full Text] [Related]
11. Natural Killer Cells Integrate Signals Received from Tumour Interactions and IL2 to Induce Robust and Prolonged Anti-Tumour and Metabolic Responses.
Kedia-Mehta N; Choi C; McCrudden A; Littwitz-Salomon E; Fox PG; Gardiner CM; Finlay DK
Immunometabolism; 2019; 1():e190014. PubMed ID: 31595191
[TBL] [Abstract][Full Text] [Related]
12. Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures.
Sabry M; Zubiak A; Hood SP; Simmonds P; Arellano-Ballestero H; Cournoyer E; Mashar M; Pockley AG; Lowdell MW
PLoS One; 2019; 14(6):e0218674. PubMed ID: 31242243
[TBL] [Abstract][Full Text] [Related]
13. Phenotype and Function of Activated Natural Killer Cells From Patients With Prostate Cancer: Patient-Dependent Responses to Priming and IL-2 Activation.
Hood SP; Foulds GA; Imrie H; Reeder S; McArdle SEB; Khan M; Pockley AG
Front Immunol; 2018; 9():3169. PubMed ID: 30761160
[No Abstract] [Full Text] [Related]
14. Weak vaccinia virus-induced NK cell regulation of CD4 T cells is associated with reduced NK cell differentiation and cytolytic activity.
Hatfield SD; Daniels KA; O'Donnell CL; Waggoner SN; Welsh RM
Virology; 2018 Jun; 519():131-144. PubMed ID: 29715623
[TBL] [Abstract][Full Text] [Related]
15. Expression and function of immune ligand-receptor pairs in NK cells and cancer stem cells: therapeutic implications.
Voutsadakis IA
Cell Oncol (Dordr); 2018 Apr; 41(2):107-121. PubMed ID: 29470831
[TBL] [Abstract][Full Text] [Related]
16. Cystatin F Affects Natural Killer Cell Cytotoxicity.
Perišić Nanut M; Sabotič J; Švajger U; Jewett A; Kos J
Front Immunol; 2017; 8():1459. PubMed ID: 29180998
[TBL] [Abstract][Full Text] [Related]
17. Differentiation by NK cells is a prerequisite for effective targeting of cancer stem cells/poorly differentiated tumors by chemopreventive and chemotherapeutic drugs.
Kozlowska AK; Topchyan P; Kaur K; Tseng HC; Teruel A; Hiraga T; Jewett A
J Cancer; 2017; 8(4):537-554. PubMed ID: 28367234
[TBL] [Abstract][Full Text] [Related]
18. Resistance to cytotoxicity and sustained release of interleukin-6 and interleukin-8 in the presence of decreased interferon-γ after differentiation of glioblastoma by human natural killer cells.
Kozlowska AK; Tseng HC; Kaur K; Topchyan P; Inagaki A; Bui VT; Kasahara N; Cacalano N; Jewett A
Cancer Immunol Immunother; 2016 Sep; 65(9):1085-97. PubMed ID: 27439500
[TBL] [Abstract][Full Text] [Related]
19. Regulation of Natural Killer Cell Function by STAT3.
Cacalano NA
Front Immunol; 2016; 7():128. PubMed ID: 27148255
[TBL] [Abstract][Full Text] [Related]
20. Adoptive transfer of osteoclast-expanded natural killer cells for immunotherapy targeting cancer stem-like cells in humanized mice.
Kozlowska AK; Kaur K; Topchyan P; Jewett A
Cancer Immunol Immunother; 2016 Jul; 65(7):835-45. PubMed ID: 27034236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
